CVE:KNE - Kane Biotech Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started C$0.08 0.00 (0.00 %) (As of 01/21/2019 08:35 AM ET)Previous CloseC$0.08Today's RangeC$0.08 - C$0.0852-Week RangeC$0.06 - C$0.11Volume45,000 shsAverage Volume32,300 shsMarket CapitalizationN/AP/E Ratio-1.86Dividend YieldN/ABetaN/A ProfileDiscussionChartEarningsInsider TradesHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Kane Biotech Inc., a biotechnology company, researches, develops, and commercializes technologies and products that prevent and remove microbial biofilms worldwide. It develops wound care solutions under the DispersinB trademark; medical device coatings under the Aledex trademark; shampoo for dogs, cats, and horses under the Alosera trademark; and pet oral care solutions under the StrixNB and bluestem trademarks. The company was founded in 2001 and is based in Winnipeg, Canada. Receive KNE News and Ratings via Email Sign-up to receive the latest news and ratings for KNE and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange CVE Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolCVE:KNE Previous Symbol CUSIPN/A Webwww.kanebiotech.com Phone+1-204-4531301Debt Debt-to-Equity Ratio187.91 Current Ratio0.28 Quick Ratio0.16Price-To-Earnings Trailing P/E Ratio-1.86 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesC$382,162.00 Price / Sales16.77 Cash FlowC$0.00 per share Price / Cash Flow40.00 Book ValueC$0.00 per share Price / Book26.67Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares80,113,504Market CapC$0.00 OptionableNot Optionable Kane Biotech (CVE:KNE) Frequently Asked Questions What is Kane Biotech's stock symbol? Kane Biotech trades on the Canadian Venture Exchange (CVE) under the ticker symbol "KNE." How were Kane Biotech's earnings last quarter? Kane Biotech Inc (CVE:KNE) posted its earnings results on Wednesday, November, 14th. The company reported ($0.01) EPS for the quarter. The company earned $0.11 million during the quarter. View Kane Biotech's Earnings History. When is Kane Biotech's next earnings date? Kane Biotech is scheduled to release their next quarterly earnings announcement on Wednesday, March 20th 2019. View Earnings Estimates for Kane Biotech. Has Kane Biotech been receiving favorable news coverage? Media coverage about KNE stock has trended positive recently, InfoTrie reports. The research group identifies negative and positive media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Kane Biotech earned a media sentiment score of 2.7 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. Who are some of Kane Biotech's key competitors? Some companies that are related to Kane Biotech include 22nd Century Group (XXII), 4d Pharma (DDDD), Abattis Bioceuticals (ATTBF), Abcam (ABC), ABcann Global (ABCN), ABLYNX NV/ADR (ABLX), ABZENA/PAR VTG FPD 0.002 (ABZA), Acasti Pharma (ACST), Acrux (ACR), Actinium Pharmaceuticals (ATNM), Actinogen Medical (ACW), Almirall (LBTSF), Altimmune (ALT), Ampio Pharmaceuticals (AMPE) and Ampliphi Biosciences (APHB). Who are Kane Biotech's key executives? Kane Biotech's management team includes the folowing people: Mr. Marc Edwards, Interim CEO & DirectorMr. Ray Dupuis, Chief Financial OfficerMr. Mark Ahrens-Townsend, AdvisorDr. Gordon Guay, Chief Scientific Officer & Member of Scientific Advisory BoardMr. L. Michael Coutts, Director of Bus. Devel. How do I buy shares of Kane Biotech? Shares of KNE and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab. What is Kane Biotech's stock price today? One share of KNE stock can currently be purchased for approximately C$0.08. What is Kane Biotech's official website? The official website for Kane Biotech is http://www.kanebiotech.com. How can I contact Kane Biotech? Kane Biotech's mailing address is 162-196 Innovation Dr, WINNIPEG, MB R3T 6C5, Canada. The company can be reached via phone at +1-204-4531301. MarketBeat Community Rating for Kane Biotech (CVE KNE)Community Ranking: 2.0 out of 5 ( )Outperform Votes: 34 (Vote Outperform)Underperform Votes: 49 (Vote Underperform)Total Votes: 83MarketBeat's community ratings are surveys of what our community members think about Kane Biotech and other stocks. Vote "Outperform" if you believe KNE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KNE will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/21/2019 by MarketBeat.com StaffFeatured Article: What type of investment options does a Roth IRA provide?